Inside ProgRET: discover our PhD projects. 👨🏻🔬 🎥 This month: Samuel Santamaria Guillén (DC4). He uses bioinformatics to decode retinal diseases! 💻 📍TIGEM, Naples, Italy Stay tuned for next month's project! 👀 #msca #inheritedretinaldisease #sciencecommunication #bioinformatics #phd
ProgRET
@progret2024.bsky.social
European Training Program for 10 brilliant PhD students to Understand, Diagnose and Treat Autosomal Dominant Retinal Diseases
Discover our PhD projects! 🎥 This month: Lihan Xu (DC3).👩🏻🔬 She generates Retinal Pigment Epithelium (RPE), a key retinal layer supporting photoreceptors, to evaluate potential treatments for BEST1-related IRDs. 📍Evotec, Göttingen, Germany #msca #inheritedretinaldisease #sciencecommunication #phd
Discover our PhD projects 👩🏻🔬 🎥 This month: Kobe Outtier (DC10) She grows mini retinas from patient cells—also known as retinal organoids—to study CRX-related inherited retinal diseases. 📍 Institute for Neurosciences of Montpellier #MSCA #InheritedRetinalDisease #ScienceCommunication #Organoids #PhD
On Rare Disease Day, we highlight the global impact of rare conditions. More than 6,000 rare diseases have been identified, together affecting 300 million people worldwide. Among them are inherited retinal diseases (IRDs), which affect about 1 in 3,000 people.
New series launch: discover our PhD projects🚀Curious what ProgRET is all about? Every month, one of our doctoral candidates is explaining their project in a short video. This is Sofia Manzo's (DC1) month🐟Look at her exciting work at the Andalusian Centre for Developmental Biology in Seville, Spain.
NEW for @forbes.com: Nobel Prize winner Jennifer Doudna’s plan to create a gene editing ecosystem to solve major problems in medicine, agriculture and climate. “I don’t want it to be a curio, a topic of academic interest,” she says. www.forbes.com/sites/amyfel...
Jennifer Doudna’s $1 Billion Plan To Bring Gene Editing To The Masses
Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer Jennifer Doudna wants to build an entire ecosystem to bring these treatments mains...
forbes.com
Meet Elfride De Baere, Head of Clinic at Ghent University Hospital’s Center for Medical Genetics. She shares why PacBio long-read sequencing + a multiomic approach (genomics + transcriptomics) can help deliver clearer insights for families. #WeCareForRare #RareDiseaseMonth #GeneticEyeDisease
Single-cell multiome and enhancer connectome of human retinal pigment epithelium and choroid nominate causal variants in macular degeneration
Single-cell multiome and enhancer connectome of human retinal pigment epithelium and choroid nominate causal variants in macular degeneration
Wang, Li, et al. apply a multi-omic framework to human retinal pigment epithelium and choroid, the earliest tissues affected in age-related macular degeneration. Using a combination of single-cell transcriptomics, single-cell epigenomics, enhancer mapping, and functional testing, they evaluate nearly 2,000 variants linked to this disease and nominate dozens as pathogenic.
dlvr.it
Careful selection of Cas13 variants and delivery methods minimizes collateral RNA degradation go.nature.com/4gEn95x rdcu.be/eZ8CF
Precise RNA targeting with CRISPR–Cas13d - Nature Biotechnology
Careful selection of Cas13 variants and delivery methods minimizes collateral RNA degradation.
go.nature.com
🚀 New preprint! @jacobsenucla.bsky.social x @doudna-lab.bsky.social collaboration: High-activity TnpB (Ymu1-WFR) + a multi-gRNA system in TRV enables heritable, tissue-culture-free multiplex editing in plants. Big potential for plant biotech 🧬🌾🌱 doi.org/10.64898/202...
doi.org
Variants in five genes have been found to cause hereditary gradual blindness go.nature.com/4b6yhsJ
Cause of vision loss discovered in overlooked genes
Non-protein-coding genes have been linked to a hereditary condition, retinitis pigmentosa, that causes progressive blindness.
go.nature.com
This CRISPR system edits DNA on a much bigger scale #NBTintheNews via @techexplorist.bsky.social www.techexplorist.com/crispr-syste...
This CRISPR system edits DNA on a much bigger scale
A new in vivo genome-editing system.
techexplorist.com
Born #OnThisDay in 1850, Sofia Kovalevskaya became the first woman in Europe to earn a doctorate in mathematics and a pioneer in analysis and partial differential equations. Join us in celebrating her brilliance and perseverance. 🌟
New preprint 👉Doudna x Bryant x Jacobsen x Savage collaboration! Work led by @zehanzhou.bsky.social, I. Saffarian-Deemyad, @honglue.bsky.social, T. Weiss We dissect how stepwise DNA unwinding gates TnpB genome editing, revealing how unwound DNA states enhance cleavage www.biorxiv.org/content/10.6...
Stepwise DNA unwinding gates TnpB genome-editing activity
TnpB is a compact RNA-guided endonuclease and evolutionary ancestor of CRISPR-Cas12 that offers a promising platform for genome engineering. However, the genome-editing activity of TnpBs remains limit...
biorxiv.org
Targeted delivery of genome editors in vivo - @doudna-lab.bsky.social @innovativegenomics.bsky.social go.nature.com/4qKp6Tb
New paper out in @natgenet.nature.com identifying a novel role for RNU non-coding genes in retinitis pigmentosa. Congrats to the ProgRET fellows and partners on this excellent work! #MSCA #DoctoralNetwork #Vision #Genetics #ScienceCommunication www.nature.com/articles/s41...
Ready for your next step to your future in genomics? Applications for the ASHG-NHGRI Post-Baccalaureate Genomics Analyst Fellowship are OPEN—submissions close Feb 1! Gain in-depth experience, learn from field leaders, and influence progress in #humangenetics research. Apply now: bit.ly/44WDkbq #ASHG
Nature research paper: Bidirectional CRISPR screens decode a GLIS3-dependent fibrotic cell circuit go.nature.com/45m7t4b
Bidirectional CRISPR screens decode a GLIS3-dependent fibrotic cell circuit - Nature
Integrated single-cell and spatial data analysis, combined with bidirectional CRISPR screens, identify the transcription factor GLIS3 as a key driver of chronic inflammation and fibrosis and a potential marker of disease severity in patients with ulcerative colitis.
go.nature.com
Accessible genomics training = career growth + representative workforce Join our Jan 27 webinar to learn how education opens doors for paraprofessionals and builds a better workforce. Register now: https://bit.ly/3Kvl4Pg #ASHG #HumanGenetics #GeneticsEducation
New international collaborative work (incl us) just out in @natgenet.nature.com showing how dominant variants in RNU genes like RNU4-2 can also cause Retinitis Pigmentosa Mathieu Quinodoz, Kim Rodenburg, Susanne Roosing, @carlorivolta.bsky.social & many others www.nature.com/articles/s41...
🧬 Major breakthrough: IOB researchers identify new genetic cause of inherited blindness in overlooked RNA genes. The discovery solves decades-old diagnostic mystery and opens new pathways for many patients worldwide. ➡️ www.nature.com/articles/s41... #AcademicBlueSky #Genetics #VisionResearch #IRDs
🚨 GRANT CALL FOR INHERITED RETINAL DISEASE RESEARCH🚨 💰 (£250,000 to £300,000 over 2 - 3 years) 👁️ Funding body: @RetinaUK 📑 Subject: Causes & treatments for inherited retinal diseases 🖥️ More info & application form: tinyurl.com/4c6rtk3a. 📅 Deadline 1 April 2026
Susan Monarez was hired and then quickly fired as head of the US Centers for Disease Control and Prevention this year. She’s part of the 2025 Nature’s 10. 🧪
The top US health director who stood up for science — and was fired
Susan Monarez is part of Nature’s 10, a list of people who shaped science in 2025.
go.nature.com
In autosomal dominant inheritance, just one defective gene can cause a condition. Key mechanisms: Dominant Negative: Faulty protein disrupts the normal one. Gain of Function: Mutant protein gains toxic function. Haploinsufficiency: One copy isn’t enough for normal function. Stay tuned for more !
New journey, new beginning! Welcome on board! Let's make this adventure amazing!💫
The true game-changer of 2024? In September, I embarked on my biggest adventure yet: moving to Ghent,Belgium🇧🇪to start my PhD in @elfridedebaere.bsky.social’s lab under the @progret2024.bsky.social fellowship.Big thanks to the lab for a warm welcome.I’m already building some unforgettable memories.👨🔬✨
Autosomal dominant IRD accounts for 25-40% of cases, posing challenges due to variable phenotypes, milder forms, and later onset. Mutations are categorized as gain-of-function, dominant-negative, or haploinsufficiency. Stay tuned as we explore these mechanisms further!